Neurallys Overview

  • Status
  • Private
  • Employees
  • 3
Employees
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Neurallys General Information

Description

Developer of a medical device designed to treat Hydrocephalus. The company's medical device is used to treat Hydrocephalus to improve the quality of live of those patients and provide the neurosurgeons with a new tool for aided-diagnosis and pathology follow-up, enabling them to reduce the cost of treatment and improve quality of care.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Surgical Devices
Primary Office
  • Boulevard de l'hôpital
  • 75013 Paris
  • France
+33 01 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurallys Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view Neurallys’s complete valuation and funding history, request access »

Neurallys Patents

Neurallys Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-3105728-A1 Cerebrospinal fluid turbidity measuring device and associated method Pending 30-Dec-2019 00000000000 0
FR-3053595-A1 Device for detecting ventriculo-peritoneal type derivation dysfunction for cephalo-spinal liquid or the like Pending 07-Jul-2016 0000000000
EP-3481486-B1 Device for detecting a malfunctioning of a ventriculoperitoneal shunt for cerebrospinal fluid Active 07-Jul-2016 0000000000
EP-3481486-A1 Device for detecting a malfunctioning of a ventriculoperitoneal shunt for cerebrospinal fluid Granted 07-Jul-2016 0000000000
US-20190307997-A1 Device for detecting a malfunctioning of a ventriculoperitoneal shunt for cerebrospinal fluid Pending 07-Jul-2016 A61M27/006

Neurallys Executive Team (2)

Name Title Board Seat Contact Info
Philippe Auvray Chief Executive Officer
Lionel Rousseau Ph.D Chief Technology Officer
To view Neurallys’s complete executive team members history, request access »

Neurallys Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neurallys Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Agoranov Accelerator/Incubator 000 0000 000000 0
To view Neurallys’s complete investors history, request access »